| 000 | 01782 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516204007.0 | ||
| 264 | 0 | _c20141208 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1757-9708 | ||
| 024 | 7 |
_a10.1039/c4ib00015c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCavnar, S P | |
| 245 | 0 | 0 |
_aMicrofluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis. _h[electronic resource] |
| 260 |
_bIntegrative biology : quantitative biosciences from nano to macro _cMay 2014 |
||
| 300 |
_a564-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzylamines |
| 650 | 0 | 4 |
_aBreast Neoplasms _ximmunology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aChemokine CXCL12 _xgenetics |
| 650 | 0 | 4 |
_aChemotaxis _ximmunology |
| 650 | 0 | 4 | _aCyclams |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeterocyclic Compounds _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMicrofluidics |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 | _aMicroscopy, Phase-Contrast |
| 650 | 0 | 4 |
_aProtein Isoforms _xgenetics |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xchemistry |
| 650 | 0 | 4 |
_aReceptors, CXCR _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 700 | 1 | _aRay, P | |
| 700 | 1 | _aMoudgil, P | |
| 700 | 1 | _aChang, S L | |
| 700 | 1 | _aLuker, K E | |
| 700 | 1 | _aLinderman, J J | |
| 700 | 1 | _aTakayama, S | |
| 700 | 1 | _aLuker, G D | |
| 773 | 0 |
_tIntegrative biology : quantitative biosciences from nano to macro _gvol. 6 _gno. 5 _gp. 564-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1039/c4ib00015c _zAvailable from publisher's website |
| 999 |
_c23683320 _d23683320 |
||